Kedrion is a leading global biopharmaceutical company specialized in the development, production and distribution of plasma-derived products. With its headquarters in Italy, companies in Europe, United States, Latin America and Asia, Kedrion distributes its products in more than 90 countries worldwide.  The company’s portfolio includes coagulation factors (Factor VIII, Factor IX, Prothrombin Complex), coagulation inhibitors (antithrombin), immunoglobulins (standards and hyperimmunes) and albumin. Kedrion‘s competitive edge relies on its state-of-the-art production facilities and on its constant commitment to research and development.